“Additional Policy and Regulatory Revisions in Response to the COVID–19 Public Health Emergency…
SUMMARY: This interim final rule with request for comments (IFC) discusses CMS’s [Centers for Medicare & Medicaid Services] implementation of section 3713 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), which established Medicare Part B coverage and payment for Coronavirus Disease 2019 (COVID–19) vaccine and its administration. This IFC implements requirements in the CARES Act that providers of COVID–19 diagnostic tests make public their cash prices for those tests and establishes an enforcement scheme to enforce those requirements. This rule also establishes an add-on payment for cases involving the use of new COVID–19 treatments under the Medicare Inpatient Prospective Payment System (IPPS). This IFC provides for separate payment for new COVID–19 treatments under the Outpatient Prospective Payment System (OPPS) for the remainder of the PHE [public health emergency] for COVID–19 when these treatments are provided at the same time as a Comprehensive Ambulatory Payment Classification (C– APC) service."
The Federal Register is a work of the United States government. Such works are not entitled to domestic copyright protection under U.S. law and are therefore in the public domain.